Thermo Fisher Scientific Inc. beat EPS estimates 94% of the time across 18 reported quarters (17 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $5.74 | — | — | Miss |
| Q1 FY2026 | $5.25 | $5.44 | +3.6% | Beat |
| Q1 FY2026 | $5.31 | — | — | Miss |
| 2026-01-29 | $6.45 | $6.57 | +1.9% | Beat |
| Q3 FY2025 | $5.50 | $5.79 | +5.3% | Beat |
| Q2 FY2025 | $5.23 | $5.36 | +2.5% | Beat |
| Q1 FY2025 | $5.10 | $5.15 | +1.0% | Beat |
| 2025-01-30 | $5.94 | $6.10 | +2.7% | Beat |
| Q3 FY2024 | $5.25 | $5.28 | +0.6% | Beat |
| Q2 FY2024 | $5.12 | $5.37 | +4.9% | Beat |
| Q1 FY2024 | $4.71 | $5.11 | +8.5% | Beat |
| 2024-01-31 | $5.64 | $5.67 | +0.5% | Beat |
Back to TMO overview · TMO holders · TMO KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.